Generic Name |
||
---|---|---|
IND |
PDR001 | |
Brand Name (US) |
||
Manufacturer |
Novartis | |
Drug Type |
||
Delivery |
Intravenous | |
Approval Status |
||
Indications |
||
Overall Strategy |
Immune system | |
Strategy |
Stimulate the immune system | |
Drug Category |
PD-1 Inhibitor |
Links |
|
|
Novartis R&D page |
Trials of this drug |
|
|
Phase I/II Study of PDR001 in Patients With Advanced Malignancies |
Trial results |